Alcohol consumption and not metabolic abnormalities is associated with increased hepatocellular carcinoma risk in patients with End-Stage Liver Disease

被引：0
|
作者：
Tamimi, Tarek I. Abu-Rajab
Hanouneh, Ibrahim A.
Hazin, Ribhi
Lopez, Rocio
Zein, Nizar N.
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A824 / A824
页数：1
相关论文
共 50 条
  • [1] Increased risk of hepatocellular carcinoma in viral hepatitis associated end-stage liver disease (ESLD).
    Perez, RG
    Zein, NN
    Steers, JL
    Wiesner, RH
    [J]. HEPATOLOGY, 1997, 26 (04) : 109 - 109
  • [2] Risk of end-stage renal disease associated with alcohol consumption
    Perneger, TV
    Whelton, PK
    Puddey, IB
    Klag, MJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1999, 150 (12) : 1275 - 1281
  • [3] INTERLEUKIN-6, GENDER AND RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH END-STAGE LIVER DISEASE
    Fumolo, E.
    Fornasiere, E.
    Bitetto, D.
    Fontanini, E.
    Cussigh, A.
    Bragagnini, W.
    Falleti, E.
    Fabris, C.
    Minisini, R.
    Toniutto, P.
    Pirisi, M.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S289 - S290
  • [4] Alpha-1 Antitrypsin Deficiency and the Risk of Hepatocellular Carcinoma in Patients With End-Stage Liver Disease
    Antoury, Clara
    Lopez, Rocio
    Zein, Nizar
    Stoller, James
    Alkhouri, Naim
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S138 - S138
  • [5] IS OBESITY ASSOCIATED WITH AN INCREASED RISK OF MORBIDITY AND MORTALITY IN PATIENTS WITH END-STAGE LIVER DISEASE REFERRED FOR LIVER TRANSPLANTATION?
    DiTeodoro, L.
    McNeil, R.
    Dickson, R.
    Pungpapong, S.
    Aranda-Michel, J.
    Keaveny, A.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S82 - S82
  • [6] PNPLA3 in end-stage liver disease: Alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival
    Friedrich, Kilian
    Wannhoff, Andreas
    Kattner, Stefan
    Brune, Maik
    Hov, Johannes Roksund
    Weiss, Karl Heinz
    Antoni, Christoph
    Dollinger, Matthias
    Neumann-Haefelin, Christoph
    Seufferlein, Thomas
    Schemmer, Peter
    Schirmacher, Peter
    Stremmel, Wolfgang
    Gotthardt, Daniel Nils
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (07) : 1477 - 1484
  • [7] MELDEQ: An Alternative Model for End-Stage Liver Disease Score for Patients With Hepatocellular Carcinoma
    Marvin, Michael R.
    Ferguson, Nicole
    Cannon, Robert M.
    Jones, Christopher M.
    Brock, Guy N.
    [J]. LIVER TRANSPLANTATION, 2015, 21 (05) : 612 - 622
  • [8] Model for end-stage liver disease score predicts survival in patients with hepatocellular carcinoma
    Contreras, C. M.
    Behrens, J.
    Cho, C. S.
    Mahvi, D. M.
    Rikkers, L. F.
    Weber, S. M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 96 - 96
  • [9] Liver Transplantation for Hepatocellular Carcinoma in the Model for End-Stage Liver Disease Era
    Levi, David M.
    Tzakis, Andreas G.
    Martin, Paul
    Nishida, Seigo
    Island, Eddie
    Moon, Jang
    Selvaggi, Gennaro
    Tekin, Akin
    Madrazo, Beatrice L.
    Narayanan, Govindarajan
    Garcia, Monica T.
    Feun, Lynn G.
    Tryphonopoulos, Panagiotis
    Skartsis, Nikolaos
    Livingstone, Alan S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 727 - 734
  • [10] Stem cell therapy for hepatocellular carcinoma and end-stage liver disease
    Abdellateif, Mona S.
    Zekri, Abdel-Rahman N.
    [J]. JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
12345